Tom , thank you , and I am not sure why some are surprised that Leronlimab is such a great drug , there are many doctors who use it and talked about it ..
Dr Harish from Montefiore Hospital is one of them.
How about Dr Otto Yang from UCLA , I think he had the most patients , all together between compassionate use , RTT and phase 3 our CD12 , I believe about 100 patients ..
And he repeated his opinion about Leronlimab few times during different conferences ..
“ Leronlimab look like a good drug , doesn’t work on everyone , but it is working on MOST”
He was talking about the patients he was treating with , those were severe / critical patients only ..
And if Leronlimab is working on MOST of these patients , it means that drug is very , very good ..
Some patients at this stage , unfortunately nothing may save , so MOST saved , only may happen with a great drug ..
And imo Leronlimab is a great drug for many diseases ..
This is because of an interesting MOA ..
And more interesting is that this drug is without serious side effects ..
I hope Dr Arman will accomplish what others couldn’t , it will be a tragic thing if this drug will be lost for us !!!!
All imo
GLTA longs ..
Bullish